ESC 365 - Finerenone in cardiovascular care: exploring a new treatment pathway.

Open Access

Finerenone in cardiovascular care: exploring a new treatment pathway.

Session: Cardiorenal benefits of finerenone: protecting the heart and kidneys

Topic: Clinical

Speaker: Professor A. Voors (Groningen, NL)

Sponsored by Bayer

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

74 presentations

0 follower

4 more presentations in this session

Welcome and introductions.

Speaker: Professor G. Filippatos (Athens, GR) Professor G. Bakris (Chicago, US)

Cardiovascular protection in patients with chronic kidney disease (CKD) and T2D: time for a new approach?

Speaker: Professor J. Bauersachs (Hannover, DE)

Finerenone use in CKD and T2D: from clinical trials to the clinic.

Speaker: Doctor P. Taub (San Diego, US) Professor G. Bakris (Chicago, US)

Q&A and close.

Access the full session

Cardiorenal benefits of finerenone: protecting the heart and kidneys

Speakers: Professor A. Voors, Professor G. Filippatos, Professor G. Bakris, Professor J. Bauersachs, Doctor P. Taub...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by